187 related articles for article (PubMed ID: 27461717)
1. Establishment and characterization of a novel human cholangiocarcinoma cell line with high metastatic activity.
Uthaisar K; Vaeteewoottacharn K; Seubwai W; Talabnin C; Sawanyawisuth K; Obchoei S; Kraiklang R; Okada S; Wongkham S
Oncol Rep; 2016 Sep; 36(3):1435-46. PubMed ID: 27461717
[TBL] [Abstract][Full Text] [Related]
2. Activation of Vimentin Is Critical to Promote a Metastatic Potential of Cholangiocarcinoma Cells.
Saentaweesuk W; Araki N; Vaeteewoottacharn K; Silsirivanit A; Seubwai W; Talabnin C; Muisuk K; Sripa B; Wongkham S; Okada S; Wongkham C
Oncol Res; 2018 May; 26(4):605-616. PubMed ID: 28762325
[TBL] [Abstract][Full Text] [Related]
3. An aberrantly spliced isoform of anterior gradient-2, AGR2vH promotes migration and invasion of cholangiocarcinoma cell.
Yosudjai J; Inpad C; Chomwong S; Dana P; Sawanyawisuth K; Phimsen S; Wongkham S; Jirawatnotai S; Kaewkong W
Biomed Pharmacother; 2018 Nov; 107():109-116. PubMed ID: 30086457
[TBL] [Abstract][Full Text] [Related]
4. O-GlcNAcylation mediates metastasis of cholangiocarcinoma through FOXO3 and MAN1A1.
Phoomak C; Silsirivanit A; Park D; Sawanyawisuth K; Vaeteewoottacharn K; Wongkham C; Lam EW; Pairojkul C; Lebrilla CB; Wongkham S
Oncogene; 2018 Oct; 37(42):5648-5665. PubMed ID: 29915392
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines.
Dokduang H; Jamnongkarn W; Promraksa B; Suksawat M; Padthaisong S; Thanee M; Phetcharaburanin J; Namwat N; Sangkhamanon S; Titapun A; Khuntikeo N; Klanrit P; Loilome W
Drug Des Devel Ther; 2020; 14():2319-2334. PubMed ID: 32606601
[TBL] [Abstract][Full Text] [Related]
6. O-GlcNAc-induced nuclear translocation of hnRNP-K is associated with progression and metastasis of cholangiocarcinoma.
Phoomak C; Park D; Silsirivanit A; Sawanyawisuth K; Vaeteewoottacharn K; Detarya M; Wongkham C; Lebrilla CB; Wongkham S
Mol Oncol; 2019 Feb; 13(2):338-357. PubMed ID: 30444036
[TBL] [Abstract][Full Text] [Related]
7. Comparative Proteomic Analysis of Human Cholangiocarcinoma Cell Lines: S100A2 as a Potential Candidate Protein Inducer of Invasion.
Wasuworawong K; Roytrakul S; Paemanee A; Jindapornprasert K; Komyod W
Dis Markers; 2015; 2015():629367. PubMed ID: 25999659
[TBL] [Abstract][Full Text] [Related]
8. CD147 augmented monocarboxylate transporter-1/4 expression through modulation of the Akt-FoxO3-NF-κB pathway promotes cholangiocarcinoma migration and invasion.
Dana P; Saisomboon S; Kariya R; Okada S; Obchoei S; Sawanyawisuth K; Wongkham C; Pairojkul C; Wongkham S; Vaeteewoottacharn K
Cell Oncol (Dordr); 2020 Apr; 43(2):211-222. PubMed ID: 31729681
[TBL] [Abstract][Full Text] [Related]
9. Mucin-producing hamster cholangiocarcinoma cell line, Ham-2, possesses the aggressive cancer phenotypes with liver and lung metastases.
Boonnate P; Vaeteewoottacharn K; Kariya R; Fujikawa S; Boonmars T; Pinlaor S; Pairojkul C; Okada S
In Vitro Cell Dev Biol Anim; 2021 Sep; 57(8):825-834. PubMed ID: 34549357
[TBL] [Abstract][Full Text] [Related]
10. Establishment and characterization of a novel cancer stem-like cell of cholangiocarcinoma.
Panawan O; Silsirivanit A; Chang CH; Putthisen S; Boonnate P; Yokota T; Nishisyama-Ikeda Y; Detarya M; Sawanyawisuth K; Kaewkong W; Muisuk K; Luang S; Vaeteewoottacharn K; Kariya R; Yano H; Komohara Y; Ohta K; Okada S; Wongkham S; Araki N
Cancer Sci; 2023 Aug; 114(8):3230-3246. PubMed ID: 37026527
[TBL] [Abstract][Full Text] [Related]
11. Establishment of cholangiocarcinoma cell lines from patients in the endemic area of liver fluke infection in Thailand.
Saensa-Ard S; Leuangwattanawanit S; Senggunprai L; Namwat N; Kongpetch S; Chamgramol Y; Loilome W; Khansaard W; Jusakul A; Prawan A; Pairojkul C; Khantikeo N; Yongvanit P; Kukongviriyapan V
Tumour Biol; 2017 Nov; 39(11):1010428317725925. PubMed ID: 29110582
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Tumor Growth against Chemoresistant Cholangiocarcinoma by a Proapoptotic Peptide Targeting Interleukin-4 Receptor.
Permpoon U; Khan F; Vadevoo SMP; Gurung S; Gunassekaran GR; Kim MJ; Kim SH; Thuwajit P; Lee B
Mol Pharm; 2020 Nov; 17(11):4077-4088. PubMed ID: 32881535
[TBL] [Abstract][Full Text] [Related]
13. Tip60 Suppresses Cholangiocarcinoma Proliferation and Metastasis via PI3k-AKT.
Zhang Y; Ji G; Han S; Shao Z; Lu Z; Huo L; Zhang J; Yang R; Feng Q; Shen H; Wang H; Li X
Cell Physiol Biochem; 2018; 50(2):612-628. PubMed ID: 30308494
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin and atorvastatin as inhibitors of proliferation and inducers of apoptosis in human cholangiocarcinoma cells.
Buranrat B; Senggunprai L; Prawan A; Kukongviriyapan V
Life Sci; 2016 May; 153():41-9. PubMed ID: 27098189
[TBL] [Abstract][Full Text] [Related]
15. Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis.
Armartmuntree N; Murata M; Techasen A; Yongvanit P; Loilome W; Namwat N; Pairojkul C; Sakonsinsiri C; Pinlaor S; Thanan R
Redox Biol; 2018 Apr; 14():637-644. PubMed ID: 29169115
[TBL] [Abstract][Full Text] [Related]
16. The Effect of the EGFR - Targeting Compound 3-[(4-Phenylpyrimidin-2-yl) Amino] Benzene-1-Sulfonamide (13f) against Cholangiocarcinoma Cell Lines.
Samatiwat P; Tabtimmai L; Suphakun P; Jiwacharoenchai N; Toviwek B; Kukongviriyapan V; Gleeson MP; Choowongkomon K
Asian Pac J Cancer Prev; 2021 Feb; 22(2):381-390. PubMed ID: 33639651
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of CD147 Promotes Metastasis of Cholangiocarcinoma by Modulating the Epithelial-to-Mesenchymal Transitional Process.
Dana P; Kariya R; Vaeteewoottacharn K; Sawanyawisuth K; Seubwai W; Matsuda K; Okada S; Wongkham S
Oncol Res; 2017 Aug; 25(7):1047-1059. PubMed ID: 28244853
[TBL] [Abstract][Full Text] [Related]
18. Intracellular IL-33 Attenuates Extracellular IL-33-induced Cholangiocarcinoma Cell Proliferation and Invasion
Yangngam S; Thongchot S; Vaeteewoottacharn K; Thuwajit P; Hermoso MA; Okada S; Thuwajit C
Anticancer Res; 2021 Oct; 41(10):4917-4928. PubMed ID: 34593439
[TBL] [Abstract][Full Text] [Related]
19. High glucose levels boost the aggressiveness of highly metastatic cholangiocarcinoma cells via O-GlcNAcylation.
Phoomak C; Vaeteewoottacharn K; Silsirivanit A; Saengboonmee C; Seubwai W; Sawanyawisuth K; Wongkham C; Wongkham S
Sci Rep; 2017 Mar; 7():43842. PubMed ID: 28262738
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-494-dependent WDHDI inhibition suppresses epithelial-mesenchymal transition, tumor growth and metastasis in cholangiocarcinoma.
Liu B; Hu Y; Qin L; Peng XB; Huang YX
Dig Liver Dis; 2019 Mar; 51(3):397-411. PubMed ID: 30314946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]